Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (301093.SZ) has a MoatMap StockRank of 28/100 based on Quality (55/100), Value (9/100), and Momentum (52/100) factor scores. The current signal is SELL. Jiangsu Hualan New Pharmaceutical manufactures pharmaceutical packaging materials. While it has decent quality metrics, it lacks the global scale, advanced biological capabilities, and pricing power of high-conviction CDMO gatekeepers.
Jiangsu Hualan New Pharmaceutical Material specializes in the manufacture of high-end pharmaceutical packaging materials, particularly rubber stoppers for sterile injectables. The company's competitive moat is established through its advanced cleanroom manufacturing facilities and stringent regulatory approvals from global health authorities. It is a leading domestic supplier, capturing significant market share in the high-barrier pharmaceutical packaging sector.
| Price | $18.08 |
| Market Cap | $3.0B |
| P/E (TTM) | 471.08 |
| Price/Book | 9.12 |
| Return on Equity | 1.9% |
| Return on Invested Capital | 3.0% |
| Debt/Equity | 3.79 |
| Gross Margin | 38.3% |
| Operating Margin | -2.6% |
| Revenue Growth | -11.0% |
| Dividend Yield | 0.1% |
| Free Cash Flow | $-1M |
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (China).